Search
Displaying 331–340 of 894 results for “vision connection”
-
Disease
Refsum disease is an inherited condition that causes vision loss, absence of the sense of smell, and a number of other symptoms.
-
No Limits for Determined Paralympian Triathlete
Beacon StoriesParalympian Elizabeth Baker says that Stargardt disease has made her a tougher person.
-
AGTC Reports Promising Interim Results for XLRP and Achromatopsia Gene Therapy Trials
Research NewsAGTC used Foundation’s My Retina Tracker registry to recruit patients for trials
-
FFB Congratulates RPE65 Gene Therapy Researchers for Champalimaud Award
Research NewsOn September 4, 2018, seven researchers, including six previously funded by the Foundation, were recognized with the prestigious 2018 Antonio Champalimaud Vision Award for their contributions to the advancement of blindness-reversing RPE65 gene therapies.
-
Persevering to Success with the Support of Family, Friends, and Faith
Beacon StoriesA story about living with retinitis pigmentosa.
-
Leber Congenital Amaurosis (LCA)
DiseaseLCA is a group of inherited retinal diseases causing blindness or severe vision loss in early childhood.
-
Clinical Trial to Launch for System Combining Optogenetics and Eyewear
Research NewsThe French biotech GenSight Biologics has received regulatory authorization in the UK to launch the PIONEER Phase 1 \ 2 clinical trial for its GS030 system — a light-sensing gene therapy (optogenetics) coupled with eyewear, which enhances visual stimulation.
-
Heather Presnar’s Story: Living with Stargardt Disease
Beacon StoriesWhen you’re the catcher, the ball always comes to you. Heather Presnar wouldn’t have had it any other way.
-
Sight and Song: The Christian Guardino Story
Beacon StoriesChristian Guardino has been singing for as long as he can remember; it’s the seeing that is something new.
-
Valproic Acid's Effect Too Small in One-Year Clinical Trial
Research NewsWhile a therapy for adRP will not emerge from the clinical trial, study investigators advanced development of a new outcome measure known as EZ Area to quickly and accurately evaluate potential therapies for RP in human studies.
